WallStSmart

MDB Capital Holdings, LLC Class A common (MDBH)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 52525052% more annual revenue ($2.17T vs $4.13M). NMR leads profitability with a 16.7% profit margin vs 0.0%. NMR earns a higher WallStSmart Score of 70/100 (B-).

MDBH

Avoid

23

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 5.0Quality: 8.5
Piotroski: 3/9Altman Z: 10.55

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDBH3 strengths · Avg: 10.0/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
10.5510/10

Safe zone — low bankruptcy risk

NMR4 strengths · Avg: 9.0/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

Areas to Watch

MDBH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$36.54M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : MDBH

The strongest argument for MDBH centers on Price/Book, Debt/Equity, Altman Z-Score.

Bull Case : NMR

The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bear Case : MDBH

The primary concerns for MDBH are EPS Growth, Market Cap, Profit Margin.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Key Dynamics to Monitor

MDBH profiles as a value stock while NMR is a growth play — different risk/reward profiles.

MDBH carries more volatility with a beta of 1.25 — expect wider price swings.

NMR is growing revenue faster at 27.5% — sustainability is the question.

MDBH generates stronger free cash flow (-3M), providing more financial flexibility.

Bottom Line

NMR scores higher overall (70/100 vs 23/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MDB Capital Holdings, LLC Class A common

FINANCIAL SERVICES · CAPITAL MARKETS · USA

MDB Capital Holdings, LLC (MDBH) is a progressive investment firm focused on driving growth in the technology and life sciences sectors through strategic capital allocation and specialized advisory services. With a seasoned management team that possesses deep industry expertise, MDBH is committed to enhancing shareholder value and generating substantial returns for institutional investors by identifying and leveraging emerging opportunities in dynamic markets. As a Class A common stock, MDBH is strategically positioned to thrive amid economic shifts, supporting its mission of fostering innovation and financial integrity while pursuing transformative growth prospects.

Visit Website →

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?